These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35799867)

  • 41. Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer.
    Kamolratanakul S; Pitisuttithum P
    Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study.
    Tabrizi SN; Brotherton JM; Kaldor JM; Skinner SR; Liu B; Bateson D; McNamee K; Garefalakis M; Phillips S; Cummins E; Malloy M; Garland SM
    Lancet Infect Dis; 2014 Oct; 14(10):958-66. PubMed ID: 25107680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
    Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
    Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The association between viral load and concurrent human papillomavirus infection at the genital and anal sites of young women and the impact of vaccination.
    van Eer K; Laâbi I; van Benthem BHB; Steenbergen RDM; King AJ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Tumour Virus Res; 2022 Jun; 13():200233. PubMed ID: 34958987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of human papillomavirus infection among women from quilombo communities in northeastern Brazil.
    Nascimento MDDSB; Vidal FCB; Silva MACND; Batista JE; Lacerda Barbosa MDC; Muniz Filho WE; Bezerra GFB; Castro Viana GM; Branco RCC; Brito LMO
    BMC Womens Health; 2018 Jan; 18(1):1. PubMed ID: 29291721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Type-specific human papillomavirus distribution in invasive cervical carcinomas in Paraguay. A study of 432 cases.
    Kasamatsu E; Cubilla AL; Alemany L; Chaux A; Tous S; Mendoza L; Paez M; Klaustermeier JE; Quint W; Lloveras B; de Sanjose S; Muñoz N; Bosch FX
    J Med Virol; 2012 Oct; 84(10):1628-35. PubMed ID: 22930512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.
    Tabrizi SN; Brotherton JM; Stevens MP; Condon JR; McIntyre P; Smith D; Garland SM;
    J Clin Virol; 2014 Jul; 60(3):250-6. PubMed ID: 24854516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An anal cancer screening program for MSM in Italy: Prevalence of multiple HPV types and vaccine-targeted infections.
    Garbuglia AR; Gentile M; Del Nonno F; Lorenzini P; Lapa D; Lupi F; Pinnetti C; Baiocchini A; Libertone R; Cicalini S; Capobianchi MR; Ammassari A
    J Clin Virol; 2015 Nov; 72():49-54. PubMed ID: 26397204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncogenic Human Papillomavirus Infection and Genotype Characterization among Women in Orodara, Western Burkina Faso.
    Traore IMA; Zohoncon TM; Ndo O; Djigma FW; Obiri-Yeboah D; Compaore TR; Guigma SP; Yonli AT; Traore G; Ouedraogo P; Ouedraogo CMR; Traore Y; Simpore J
    Pak J Biol Sci; 2016; 19(7):306-311. PubMed ID: 29023032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test.
    van Hamont D; van Ham MA; Bakkers JM; Massuger LF; Melchers WJ
    J Clin Microbiol; 2006 Sep; 44(9):3122-9. PubMed ID: 16954236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HPV genotype distribution in older Danish women undergoing surgery due to cervical cancer.
    Hammer A; Mejlgaard E; Gravitt P; Høgdall E; Christiansen P; Steiniche T; Blaakaer J
    Acta Obstet Gynecol Scand; 2015 Nov; 94(11):1262-8. PubMed ID: 26300424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and Distribution of Vaccine-Preventable Genital Human Papillomavirus(HPV) Genotypes in Ghanaian Women Presenting for Screening.
    Donkoh ET; Asmah RH; Agyemang-Yeboah F; Dabo EO; Wiredu EK
    Cancer Control; 2022; 29():10732748221094721. PubMed ID: 35536890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy.
    Mariani L; Monfulleda N; Alemany L; Vizza E; Marandino F; Vocaturo A; Benevolo M; Quirós B; Lloveras B; Klaustermeier JE; Quint W; de Sanjosé S; Bosch FX
    BMC Cancer; 2010 Jun; 10():259. PubMed ID: 20525370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection.
    Couture MC; Page K; Stein ES; Sansothy N; Sichan K; Kaldor J; Evans JL; Maher L; Palefsky J
    BMC Infect Dis; 2012 Jul; 12():166. PubMed ID: 22839728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acceptability and feasibility of self-sampling and follow-up attendance after text message delivery of human papillomavirus results: A cross-sectional study nested in a cohort in rural Tanzania.
    Mremi A; Linde DS; Mchome B; Mlay J; Schledermann D; Blaakaer J; Rasch V
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):802-810. PubMed ID: 33555038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.
    Wirtz C; Mohamed Y; Engel D; Sidibe A; Holloway M; Bloem P; Kumar S; Brotherton J; Reis V; Morgan C
    Vaccine; 2022 Mar; 40 Suppl 1():A116-A123. PubMed ID: 34863615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy.
    Piana A; Sotgiu G; Castiglia P; Pischedda S; Cocuzza C; Capobianco G; Marras V; Dessole S; Muresu E
    BMC Public Health; 2011 Oct; 11():785. PubMed ID: 21989375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genotypes distribution of human papillomavirus in cervical samples of Ecuadorian women.
    García Muentes GD; García Rodríguez LK; Burgos Galarraga RI; Almeida Carpio F; Ruiz Cabezas JC
    Rev Bras Epidemiol; 2016 Mar; 19(1):160-6. PubMed ID: 27167657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.
    Campos NG; Sharma M; Clark A; Lee K; Geng F; Regan C; Kim J; Resch S
    Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():47-56. PubMed ID: 28691334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-Utility Analysis of Human Papillomavirus Vaccination and Cervical Screening on Cervical Cancer Patient in Indonesia.
    Setiawan D; Dolk FC; Suwantika AA; Westra TA; WIlschut JC; Postma MJ
    Value Health Reg Issues; 2016 May; 9():84-92. PubMed ID: 27881267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.